Skip to main content

Advertisement

Log in

Migraine Chronification

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Migraine is a disorder with variable natural history. In some sufferers, migraine evolves over time into a state of headaches on more days than not. This process of migraine chronification is poorly understood, but risk factors have been clearly identified. Herein, we first discuss the role of heritability and of genetic risk factors on migraine chronification. We follow with a discussion of the role of comorbid conditions and environmental exposures. We suggest that clinicians consider risk factor modification as part of migraine management, aspiring to not just relieve current pain and disability, but to avoid migraine progression. Reducing attack frequency, avoiding medication overuse, appropriately using preventive drugs and behavioral therapies, and encouraging weight loss should be part of migraine therapy to improve current pain and disability and also to avoid future pain and disability by preventing chronification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •Of importance •• Of major importance

  1. Haut SR, Bigal ME, Lipton RB: Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 2006;5(2):148-57.

    Article  PubMed  Google Scholar 

  2. Di Clemente L, Coppola G, Magis D, et al.: Interictal habituation deficit of the nociceptive blink reflex: an endophenotypic marker for presymptomatic migraine? In: Brain; 2007. p. 765-70.

    Google Scholar 

  3. Terwindt GM, Ferrari MD, Tijhuis M, et al.: The impact of migraine on quality of life in the general population. The GEM Study. In: Neurology; 2000. p. 624-629.

  4. • Bigal ME, Lipton RB: Clinical course in migraine: conceptualizing migraine transformation. Neurology 2008;71(11):848-55. This is a review on the natural history of migraine.

  5. Bigal ME, Lipton RB: The prognosis of migraine. Curr Opin Neurol 2008;21(3):301-8.

    Article  PubMed  Google Scholar 

  6. Pryse-Phillips W, Aube M, Bailey P, et al.: A clinical study of migraine evolution. Headache 2006;46(10):1480-6.

    Article  PubMed  Google Scholar 

  7. Lipton RB, Bigal ME: Migraine: epidemiology, impact, and risk factors for progression. Headache 2005;45 Suppl 1:S3-S13.

    Article  PubMed  Google Scholar 

  8. Kruit MC, van Buchem MA, Hofman PA, et al.: Migraine as a risk factor for subclinical brain lesions. In: Journal of the American Medical Association; 2004. p. 427-434.

    Google Scholar 

  9. Russell MB, Olesen J: Migrainous disorder and its relation to migraine without aura and migraine with aura. A genetic epidemiological study. Cephalalgia 1996;16(6):431-5.

    Article  PubMed  CAS  Google Scholar 

  10. Ulrich V, Gervil M, Fenger K, et al.: The prevalence and characteristics of migraine in twins from the general population. Headache 1999;39(3):173-80.

    Article  PubMed  CAS  Google Scholar 

  11. Max MB, Wu T, Atlas SJ, et al.: A clinical genetic method to identify mechanisms by which pain causes depression and anxiety. Mol Pain 2006;2:14.

    Article  PubMed  Google Scholar 

  12. Diatchenko L, Nackley AG, Slade GD, et al.: Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006;125(3):216-24.

    Article  PubMed  CAS  Google Scholar 

  13. Goldman D, Oroszi G, Ducci F: The genetics of addictions: uncovering the genes. Nat Rev Genet 2005;6(7):521-32.

    Article  PubMed  CAS  Google Scholar 

  14. Hagen K, Einarsen C, Zwart JA, et al.: The co-occurrence of headache and musculoskeletal symptoms amongst 51 050 adults in Norway. Eur J Neurol 2002;9(5):527-33.

    Article  PubMed  CAS  Google Scholar 

  15. Buck KJ, Finn DA: Genetic factors in addiction: QTL mapping and candidate gene studies implicate GABAergic genes in alcohol and barbiturate withdrawal in mice. Addiction 2001;96(1):139-49.

    Article  PubMed  CAS  Google Scholar 

  16. Brent RL, Tanski S, Weitzman M: A pediatric perspective on the unique vulnerability and resilience of the embryo and the child to environmental toxicants: the importance of rigorous research concerning age and agent. Pediatrics 2004;113(4 Suppl):935-44.

    PubMed  Google Scholar 

  17. Handmaker NS, Rayburn WF, Meng C, et al.: Impact of alcohol exposure after pregnancy recognition on ultrasonographic fetal growth measures. Alcohol Clin Exp Res 2006;30(5):892-8.

    Article  PubMed  CAS  Google Scholar 

  18. Arruda MA, Guidetti V, Galli F, Albuquerque RCAP, Bigal ME. Prenatal tabagism and alcohol intake are associated with chronic daily headaches at childhood. A population-based study. Pain 2010;In press.

  19. Scher AI, Stewart WF, Ricci JA, Lipton RB: Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003;106(1-2):81-9.

    Article  PubMed  CAS  Google Scholar 

  20. Katsarava Z, Schneeweiss S, Kurth T, et al.: Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004;62(5):788-90.

    PubMed  CAS  Google Scholar 

  21. Welch KM, Nagesh V, Aurora SK, Gelman N: Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001;41(7):629-37.

    Article  PubMed  CAS  Google Scholar 

  22. Burstein R, Collins B, Jakubowski M: Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004;55(1):19-26.

    Article  PubMed  CAS  Google Scholar 

  23. Selby G, Lance JW: Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry 1960;23:23-32.

    Article  PubMed  CAS  Google Scholar 

  24. Burstein R, Yarnitsky D, Goor-Aryeh I, et al.: An association between migraine and cutaneous allodynia. Ann Neurol 2000;47(5):614-24.

    Article  PubMed  CAS  Google Scholar 

  25. Lipton RB, Bigal ME, Ashina S, et al.: Cutaneous allodynia in the migraine population. Ann Neurol 2008;63(2):148-58.

    Article  PubMed  Google Scholar 

  26. Bigal ME, Ashina S, Burstein R, et al.: Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 2008;70(17):1525-33.

    Article  PubMed  CAS  Google Scholar 

  27. Stewart WF, Staffa J, Lipton RB, Ottman R: Familial risk of migraine: a population-based study. Ann Neurol 1997;41(2):166-72.

    Article  PubMed  CAS  Google Scholar 

  28. •• Arruda MA, Guidetti V, Galli F, et al.: Frequency of headaches in children is influenced by headache status in the mother. Headache 2010;50(6):973-80. This is a study suggesting that frequency of headache aggregates in the family.

  29. Bigal ME, Liberman JN, Lipton RB: Obesity and migraine: a population study. Neurology 2006;66(4):545-50.

    Article  PubMed  Google Scholar 

  30. Bigal ME, Tsang A, Loder E, et al.: Body mass index and episodic headaches: a population-based study. Arch Intern Med 2007;167(18):1964-70.

    Article  PubMed  Google Scholar 

  31. Jennum P, Sjol A: Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30-60. J Sleep Res 1992;1(4):240-244.

    Article  PubMed  Google Scholar 

  32. Scher AI, Lipton RB, Stewart WF: Habitual snoring as a risk factor for chronic daily headache. Neurology 2003;60(8):1366-8.

    PubMed  CAS  Google Scholar 

  33. Zwart JA, Dyb G, Hagen K, et al.: Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 2003;10(2):147-52.

    Article  PubMed  Google Scholar 

  34. Karakurum B, Soylu O, Karatas M, et al.: Personality, depression, and anxiety as risk factors for chronic migraine. Int J Neurosci 2004;114(11):1391-9.

    Article  PubMed  Google Scholar 

  35. •• Scher AI, Stewart WF, Buse D, et al.: Major life changes before and after the onset of chronic daily headache: a population-based study. Cephalalgia 2008;28(8):868-76. This is a study suggesting the additive role of stressful life events as a risk for migraine progression.

  36. Bevilaqua Grossi D, Lipton RB, Bigal ME: Temporomandibular disorders and migraine chronification. Curr Pain Headache Rep 2009;13(4):314-8.

    Google Scholar 

  37. Goncalves DA, Bigal ME, Jales LC, et al.: Headache and Symptoms of Temporomandibular Disorder: An Epidemiological Study. Headache 2009.

  38. • Goncalves DA, Speciali JG, Jales LC, et al.: Temporomandibular symptoms, migraine, and chronic daily headaches in the population. Neurology 2009;73(8):645-6. This is a study showing the additive role of TMD symptoms as a risk for migraine progression.

  39. Bevilaqua-Grossi D, Lipton RB, Napchan U, et al.: Temporomandibular disorders and cutaneous allodynia are associated in individuals with migraine. Cephalalgia 2009.

  40. Goadsby PJ: Is medication-overuse headache a distinct biological entity? Nat Clin Pract Neurol 2006;2(8):401.

    Article  PubMed  Google Scholar 

  41. Bahra A, Walsh M, Menon S, Goadsby PJ: Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003;43(3):179-90.

    Article  PubMed  Google Scholar 

  42. Wilkinson SM, Becker WJ, Heine JA: Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001;41(3):303-9.

    Article  PubMed  CAS  Google Scholar 

  43. Zwart JA, Dyb G, Hagen K, et al.: Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 2003;61(2):160-4.

    PubMed  Google Scholar 

  44. •• Bigal ME, Serrano D, Buse D, et al.: Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008;48(8):1157-68. This is the first longitudinal study to demonstrate that excessive use of medication increases headache frequency.

  45. Shapiro RE: Caffeine and headaches. Curr Pain Headache Rep 2008;12(4):311-5.

    Article  PubMed  Google Scholar 

  46. Scher AI, Stewart WF, Lipton RB: Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 2004;63(11):2022-7.

    PubMed  CAS  Google Scholar 

  47. Silverman K, Evans SM, Strain EC, Griffiths RR: Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992;327(16):1109-14.

    Article  PubMed  CAS  Google Scholar 

  48. Couch JR, Lipton RB, Stewart WF, Scher AI: Head or neck injury increases the risk of chronic daily headache: a population-based study. Neurology 2007;69(11):1169-77.

    Article  PubMed  Google Scholar 

  49. Paemeleire K, Evers S, Goadsby PJ: Medication-overuse headache in patients with cluster headache. Curr Pain Headache Rep 2008;12(2):122-7.

    Article  PubMed  Google Scholar 

  50. Williams L, O'Connell K, Tubridy N: Headaches in a rheumatology clinic: when one pain leads to another. Eur J Neurol 2008;15(3):274-7.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

Conflicts of interest: M.E. Bigal: is a full-time employee of Merck; R.B. Lipton: none.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcelo E. Bigal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bigal, M.E., Lipton, R.B. Migraine Chronification. Curr Neurol Neurosci Rep 11, 139–148 (2011). https://doi.org/10.1007/s11910-010-0175-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-010-0175-6

Keywords

Navigation